No profile data available.
NeOnc Technologies Holdings, Inc. (NTHI) is a healthcare company in the additional cancer treatment drugs industry, based in Calabasas, United States, with about 5 full-time employees.
It reported revenue of $39,990 for fiscal year 2025, down 51.8% from fiscal year 2024, and net income of -$62.15 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $80.08 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.
NeOnc Technologies reported $39,990 in revenue for fiscal year 2025, down 51.8% from $83,000 in fiscal year 2024. In Q2 2026 revenue was $0.
$80.08 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include OnKure Therapeutics, Inc. (OKUR), Context Therapeutics Inc. (CNTX), Acrivon Therapeutics, Inc. (ACRV), Sutro Biopharma, Inc. (STRO).